The 2nd Annual Oncology Biomarkers Conference

Biomarkers in Medicine

Volumn 3, Issue 2, 2009, Pages 203-209

  Schiffer, Eric ^a  

^a MOSAIQUES DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PANITUMUMAB; TUMOR MARKER;

BLADDER CANCER; BREAST CANCER; CANCER GRADING; CANCER IMMUNIZATION; CLINICAL PROTOCOL; COLORECTAL CANCER; CONFERENCE PAPER; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOMICS; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; METABOLOMICS; NONHUMAN; ONCOLOGY; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PROGNOSIS; PROSTATE CANCER; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SYMPOSIUM; TRANSCRIPTOMICS; VALIDATION PROCESS;

EID: 68049100064     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.8     Document Type: Conference Paper

References (1)

1. Hayes DF, Bast RC, Desch CE et al.: Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J. Natl Cancer Inst. 88(20), 1456-1466 (1996).